Investment
Portfolio company Earendil Labs announced $787 million in financing to scale AI-driven biologics discovery and development.
Earendil Labs
APR 13, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Earendil Labs
Bambusa Therapeutics
INCE portfolio companies at CES 2026
Forbes China's Top 100 Venture Capitalists 2025
WEFLY
Bambusa Therapeutics
LiblibAI
Avenzo Therapeutics
Dyna
Ronovo Surgical
WEFLY
LiblibAI
Jireh Li joined as Partner